Adjunctive Transcranial Stimulation to Reduce Impulsivity in Opiate Use Disorder
Key facts
- Who runs it
- Gopalkumar Rakesh
- Where
- Lexington, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 23 people enrolled
- Started
- 15 Sept 2021
- Ended
- 31 Jul 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Theta Burst Stimulation
- Sham TMS
- Record updated
- 22 October 2025
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (14)Hide the full registry criteria
Who can take part
- Patients enrolled in the SMART Clinic at University of Kentucky
- 18-60 years of age
- Preferably right hand dominant
- Currently self-report smoking 10 of more cigarettes per day or a score of > 5 on the Fagerstrom Test for Nicotine
- Willing and able to abstain from all drug use
- Exhaled breath on day of study CO < 10 ppm
- Stabilized on maintenance buprenorphine if having comorbid opioid use disorder
- Able to read and speak English
- Able to provide informed consent to participate
Who cannot take part
- Increased risk of seizure for any reason, including prior diagnosis of epilepsy, seizure disorder, increased intracranial pressure, or history of significant head trauma with loss of consciousness for ≥ 5 minutes which are all contraindications for TMS
- History of traumatic brain injury or seizures which are contraindications for transcranial magnetic stimulation (TMS)
- Presence of intracranial implants (e.g. aneurysms clips, shunts, stimulators, cochlear implants, or electrodes), cardiac pacemakers, or vagus nerve stimulation device which are all contraindications for magnetic resonance imaging
- Neurological disorder including, but not limited to: space occupying brain lesion; any history of seizures, history of cerebrovascular accident; fainting, cerebral aneurysm, major neurocognitive disorder, Huntington chorea; multiple sclerosis which are all contraindications for TMS
- Pregnant, nursing, or becoming pregnant during the study
Where in United States
- 245 Fountain CourtLexington, United States
About the trial
What the trial wants to find out
The goal of this study is to examine the effect of four sessions of theta burst stimulation (TBS) versus sham TMS on attentional bias for smoking and opioid cues versus neutral stimuli in a population of patients with tobacco use disorder (TUD) with comorbid opioid use disorder (OUD) that is stable and on treatment with buprenorphine. The investigators will also examine the effect of TBS on craving for cigarettes as well as opioids. Participants will perform a stress induction procedure that mirrors an optimum combination of cues that trigger tonic craving in their environment while exposed to stress. All four sessions of TBS/sham TMS will be performed on the same day, with each session lasting for approximately 10 minutes and separated by 50 minute intervals.
The 2 groups in the trial
- Active interventionExisting treatment, for comparison
Four sessions of theta burst stimulation, amounting to 7200 pulses at 120% resting motor threshold. Targeting will be done using neuronavigation and processed resting state brain scan.
Treatment: Theta Burst Stimulation
- Sham TMSPlacebo, for comparison
Four sessions of sham TMS. Targeting will be done using neuronavigation and processed resting state brain scan.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Comparing cigarette-cue attentional bias between people with HIV/AIDS and people with opioid use disorder who smoke.Health psychology and behavioral medicine, 2023
- Record updated
- 22 October 2025